financetom
Business
financetom
/
Business
/
Gladius Communications Acquires Kylee Social to Expand Digital & Social Media Capabilities
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gladius Communications Acquires Kylee Social to Expand Digital & Social Media Capabilities
Oct 8, 2025 6:42 AM

ALEXANDRIA, Va., Oct. 8, 2025 /PRNewswire/ -- Gladius Communications, a leader in strategic and transformation communications, announced today that it has acquired Kylee Social, a boutique digital and social media agency, to deepen its data-driven creative and digital engagement capabilities.

Kylee Social founder and CEO Paige Knapp will join Gladius to lead the firm's new digital and social media practice area as Vice President. This strategic move enables Gladius to deliver fully integrated, end-to-end communications programs—combining high-level business strategy and counsel with sustained, measurable digital activation and community management.

The addition of Kylee Social strengthens Gladius' ability to deliver fully integrated communications programs that pair high-level strategy and counsel with planning and execution of sustained digital activation and community management. Clients of both firms will benefit from the combined capabilities in change communications, transformation, public relations, thought leadership, employee engagement, digital content, social media management, analytics, and paid social advisory services.

"Combining forces with Gladius gives our team the scale and strategic breadth to amplify the impact we've built for clients since our inception in 2020," said Paige Knapp, founder and CEO of Kylee Social. "By integrating a data-driven approach and social-first expertise with Gladius' strategic depth, we can help clients create greater business impact, stay ahead of trends, and tell richer stories than ever before."

B.J. Talley, Founder & President of Gladius Communications, added: "We built Gladius to be a partner that enables real transformation and unlocks growth potential. Paige and the team at Kylee Social are absolute experts in the digital and social media space and bring with them an impressive group of clients. Together, we are better positioned to help clients accelerate growth, build stronger audience communities, and measure clear, meaningful business outcomes."

This marks the second strategic acquisition for Gladius since October 2024, demonstrating the firm's commitment to building a modern, comprehensive communications solution. The firm previously acquired Marcoux Strategies to augment its corporate communications solutions offering for the defense technology sector.

About Gladius Communications

Gladius Communications is a strategic and transformation communications agency founded by former in-house corporate communicators. The firm helps organizations leverage communications to grow, transform, build, and protect their operations and reputations by aligning communications to business goals and outcomes.

About Kylee Social

Kylee Social is a digital-driven social media agency specializing in social strategy, content creation, community management, executive social thought leadership, and social-first video production. The team combines data-driven strategy, creative digital storytelling, and precise execution to enhance visibility, foster deeper audience connection, and deliver measurable business results. Founded in 2020 by Paige Knapp and Kylee Social, the company has supported clients ranging from startups to Fortune 500 corporations, with a special expertise in highly regulated industries. 

CONTACT: [email protected]

View original content:https://www.prnewswire.com/news-releases/gladius-communications-acquires-kylee-social-to-expand-digital--social-media-capabilities-302577977.html

SOURCE Gladius Communications

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US awards contracts for making higher enriched uranium for new reactors
US awards contracts for making higher enriched uranium for new reactors
Oct 17, 2024
WASHINGTON, Oct 17 (Reuters) - The U.S. rolled out initial contracts to four companies hoping to produce a new, more highly enriched uranium fuel for an expected wave of high-tech reactors, the U.S. Energy Department said on Thursday. Russia is currently the only country that makes the fuel called high-assay low-enriched uranium fuel, or HALEU, in commercial volumes. Funds to...
Merck's RSV antibody for infants shows over 60% efficacy in mid-late-stage study
Merck's RSV antibody for infants shows over 60% efficacy in mid-late-stage study
Oct 17, 2024
Oct 17 (Reuters) - Merck ( MRK ) said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing respiratory syncytial virus (RSV) infections in infants. The seasonal shot met its primary goal in the mid-to-late stage trial, reducing the incidence of lower respiratory tract infections in healthy infants up to one year of age entering their...
US regional banks capitalize on rising deal fees to counter high deposit costs
US regional banks capitalize on rising deal fees to counter high deposit costs
Oct 17, 2024
(Reuters) - U.S. regional banks' profits outdid Wall Street expectations in the third quarter as their investment banking fees surged from a revival in dealmaking and helped offset higher deposit costs.  Underwriting and M&A activity picked up pace, taking advantage of a stock market rally and leaning on a combination of economic resilience and hopes of more cuts in interest...
Supernus Pharmaceuticals Reports 'Promising' Data in Trial of Anti-Depression Drug Candidate
Supernus Pharmaceuticals Reports 'Promising' Data in Trial of Anti-Depression Drug Candidate
Oct 17, 2024
06:01 PM EDT, 10/17/2024 (MT Newswires) -- Supernus Pharmaceuticals ( SUPN ) said late Thursday the phase 2a open-label study of SPN-820 in adults with major depressive disorder yielded promising data. The company said the study evaluated the safety and tolerability of a 2400 mg dose of the investigational drug given once every three days as an adjunctive treatment to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved